GlyRS-IN-1
GlyRS-IN-1 is a glycyl-tRNA synthase (GlyRS) inhibitor extracted from patent WO 2017066459 A1. GlyRS-IN-1 can also inhibit the growth of bacteria[1].
Product Specifications
CAS Number
112921-11-6
UNSPSC
12352005
Target
Aminoacyl-tRNA Synthetase; Bacterial
Type
Reference compound
Related Pathways
Anti-infection; Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer; Infection
Assay Protocol
https://www.medchemexpress.com/GlyRS-IN-1.html
Purity
99.40
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
NC1=C2N=CN([C@@H]([C@H](O)[C@@H]3O)O[C@@H]3COS(=O)(NC(CN)=O)=O)C2=NC=N1
Molecular Formula
C12H17N7O7S
Molecular Weight
403.37
References & Citations
[1]Xiang-Lei Yang, et al. INHIBITION OF NEDDYLATION USING GLYCYL-tRNA SYNTHETASE INHIBITORS. WO 2017066459 A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2251804 1.0 µg DNA
SNRPEL1 sgRNA CRISPR Lentivector (Human) (Target 3)
Sign In for Pricing
View Details